A detailed history of Resources Investment Advisors, Llc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Resources Investment Advisors, Llc. holds 1,731 shares of VRTX stock, worth $820,770. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,731
Previous 1,821 4.94%
Holding current value
$820,770
Previous $761,000 6.57%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$392.81 - $485.53 $35,352 - $43,697
-90 Reduced 4.94%
1,731 $811,000
Q1 2024

May 10, 2024

SELL
$407.69 - $446.08 $291,906 - $319,393
-716 Reduced 28.22%
1,821 $761,000
Q4 2023

Feb 13, 2024

SELL
$343.0 - $410.68 $189,679 - $227,106
-553 Reduced 17.9%
2,537 $1.03 Million
Q3 2023

Nov 14, 2023

BUY
$338.18 - $362.46 $519,444 - $556,738
1,536 Added 98.84%
3,090 $1.07 Million
Q2 2023

Aug 07, 2023

SELL
$314.42 - $351.91 $405,287 - $453,611
-1,289 Reduced 45.34%
1,554 $546,000
Q1 2023

May 10, 2023

BUY
$283.23 - $323.1 $602,146 - $686,910
2,126 Added 296.51%
2,843 $895,000
Q4 2022

Feb 02, 2023

BUY
$285.76 - $321.48 $204,889 - $230,501
717 New
717 $207,000
Q3 2021

Nov 05, 2021

SELL
$181.39 - $202.99 $193,361 - $216,387
-1,066 Closed
0 $0
Q2 2021

Aug 09, 2021

BUY
$187.49 - $221.1 $199,864 - $235,692
1,066 New
1,066 $214,000
Q4 2020

Feb 08, 2021

SELL
$207.01 - $276.09 $160,432 - $213,969
-775 Closed
0 $0
Q3 2020

Oct 09, 2020

SELL
$255.65 - $303.1 $108,651 - $128,817
-425 Reduced 35.42%
775 $210,000
Q2 2020

Aug 14, 2020

BUY
$225.48 - $295.8 $62,908 - $82,528
279 Added 30.29%
1,200 $348,000
Q1 2020

May 14, 2020

BUY
$199.77 - $247.81 $183,988 - $228,233
921 New
921 $219,000
Q3 2019

Nov 08, 2019

SELL
$166.23 - $187.09 $25,765 - $28,998
-155 Closed
0 $0
Q2 2019

Aug 12, 2019

SELL
$164.61 - $190.37 $823 - $951
-5 Reduced 3.13%
155 $0
Q4 2018

Feb 12, 2019

BUY
$151.91 - $192.21 $24,305 - $30,753
160 New
160 $27,000
Q3 2018

Nov 07, 2018

SELL
$167.73 - $192.74 $20,966 - $24,092
-125 Closed
0 $0
Q2 2018

Aug 15, 2018

SELL
$145.72 - $169.96 $1,457 - $1,699
-10 Reduced 7.41%
125 $21,000
Q1 2018

May 14, 2018

SELL
$151.6 - $177.13 $25,014 - $29,226
-165 Reduced 55.0%
135 $22,000
Q3 2017

Nov 13, 2017

SELL
$148.13 - $162.24 $25,922 - $28,392
-175 Reduced 36.84%
300 $46,000
Q2 2017

Aug 14, 2017

BUY
N/A
475
475 $61,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $122B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Resources Investment Advisors, Llc. Portfolio

Follow Resources Investment Advisors, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resources Investment Advisors, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Resources Investment Advisors, Llc. with notifications on news.